Myasthenia gravis and immunity. A review of basic mechanisms.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000818:Animals; D000918:Antibody Specificity; D001327:Autoimmune Diseases; D004195:Disease Models, Animal; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000276:immunology; D009135:Muscular Diseases / Q000150:complications / Q000276:immunology; D009157:Myasthenia Gravis / Q000209:etiology / Q000276:immunology* / Q000628:therapy; D011247:Pregnancy; D011485:Protein Binding; D013934:Thymectomy; D013950:Thymus Gland / Q000276:immunology* / Q000528:radiation effects; D005719:gamma-Globulins / Q000032:analysis
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D000324:Adrenocorticotropic Hormone